Search

Julie Ha

Examiner (ID: 17647, Phone: (571)272-5982 , Office: P/1675 )

Most Active Art Unit
1654
Art Unit(s)
1654, 1675
Total Applications
1488
Issued Applications
934
Pending Applications
118
Abandoned Applications
454

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18055588 [patent_doc_number] => 20220386674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => USE OF ALPHA-LACTALBUMIN ENRICHED WHEY PROTEIN EXTRACT AS A SOURCE OF CHOLESTEROL [patent_app_type] => utility [patent_app_number] => 17/755939 [patent_app_country] => US [patent_app_date] => 2020-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5870 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17755939 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/755939
USE OF ALPHA-LACTALBUMIN ENRICHED WHEY PROTEIN EXTRACT AS A SOURCE OF CHOLESTEROL Nov 8, 2020 Pending
Array ( [id] => 16791730 [patent_doc_number] => 20210121547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-29 [patent_title] => PROGESTERONE-ASSOCIATED ENDOMETRIAL PROTEIN (PAEP) AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/092715 [patent_app_country] => US [patent_app_date] => 2020-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10219 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17092715 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/092715
PROGESTERONE-ASSOCIATED ENDOMETRIAL PROTEIN (PAEP) AND USES THEREOF Nov 8, 2020 Abandoned
Array ( [id] => 16792967 [patent_doc_number] => 20210122784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-29 [patent_title] => PEPTIDES DERIVED FROM SOLUTE CARRIER FAMILY 45 MEMBER 2 (SLC45A2) AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/092970 [patent_app_country] => US [patent_app_date] => 2020-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9939 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17092970 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/092970
PEPTIDES DERIVED FROM SOLUTE CARRIER FAMILY 45 MEMBER 2 (SLC45A2) AND USES THEREOF Nov 8, 2020 Abandoned
Array ( [id] => 18478281 [patent_doc_number] => 11692011 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-04 [patent_title] => Hepatitis B virus-derived polypeptide and anti-viral use thereof [patent_app_type] => utility [patent_app_number] => 17/090485 [patent_app_country] => US [patent_app_date] => 2020-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 40 [patent_no_of_words] => 9537 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17090485 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/090485
Hepatitis B virus-derived polypeptide and anti-viral use thereof Nov 4, 2020 Issued
Array ( [id] => 17435910 [patent_doc_number] => 11261222 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-01 [patent_title] => Transdermal peptide with nuclear localization ability and use thereof [patent_app_type] => utility [patent_app_number] => 17/090125 [patent_app_country] => US [patent_app_date] => 2020-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 3799 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17090125 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/090125
Transdermal peptide with nuclear localization ability and use thereof Nov 4, 2020 Issued
Array ( [id] => 17007076 [patent_doc_number] => 20210238237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => METHOD OF MANAGING JOINT PAIN [patent_app_type] => utility [patent_app_number] => 17/085023 [patent_app_country] => US [patent_app_date] => 2020-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11308 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085023 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/085023
Method of managing joint pain Oct 29, 2020 Issued
Array ( [id] => 18559802 [patent_doc_number] => 11725036 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-15 [patent_title] => Modified lipidated relaxin B chain peptides and their therapeutic use [patent_app_type] => utility [patent_app_number] => 17/086183 [patent_app_country] => US [patent_app_date] => 2020-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16838 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17086183 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/086183
Modified lipidated relaxin B chain peptides and their therapeutic use Oct 29, 2020 Issued
Array ( [id] => 18364942 [patent_doc_number] => 20230146533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => KERATIN BD-10, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITION AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/772756 [patent_app_country] => US [patent_app_date] => 2020-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11031 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17772756 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/772756
KERATIN BD-10, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITION AND USE THEREOF Oct 27, 2020 Abandoned
Array ( [id] => 16715390 [patent_doc_number] => 20210082537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => SELECTIVE PEPTIDE ANTAGONISTS [patent_app_type] => utility [patent_app_number] => 17/083099 [patent_app_country] => US [patent_app_date] => 2020-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22727 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17083099 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/083099
Selective peptide antagonists Oct 27, 2020 Issued
Array ( [id] => 16990270 [patent_doc_number] => 20210228690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => Anti-Inflammatory Peptides and Composition Comprising the Same [patent_app_type] => utility [patent_app_number] => 17/080653 [patent_app_country] => US [patent_app_date] => 2020-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11725 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17080653 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/080653
Anti-inflammatory peptides and composition comprising the same Oct 25, 2020 Issued
Array ( [id] => 20187091 [patent_doc_number] => 12398196 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-26 [patent_title] => Fused polypeptide with multifunctional activities and use thereof [patent_app_type] => utility [patent_app_number] => 17/635962 [patent_app_country] => US [patent_app_date] => 2020-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 2431 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17635962 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/635962
Fused polypeptide with multifunctional activities and use thereof Oct 25, 2020 Issued
Array ( [id] => 16620051 [patent_doc_number] => 20210038704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-11 [patent_title] => H3.3 CTL PEPTIDES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/077806 [patent_app_country] => US [patent_app_date] => 2020-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15937 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17077806 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/077806
H3.3 CTL peptides and uses thereof Oct 21, 2020 Issued
Array ( [id] => 17741460 [patent_doc_number] => 11389505 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-19 [patent_title] => Method of managing joint pain [patent_app_type] => utility [patent_app_number] => 17/067278 [patent_app_country] => US [patent_app_date] => 2020-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11337 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17067278 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/067278
Method of managing joint pain Oct 8, 2020 Issued
Array ( [id] => 18747053 [patent_doc_number] => 11806342 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-07 [patent_title] => Diiodohydroxyquinoline for the treatment of clostridium difficile infection [patent_app_type] => utility [patent_app_number] => 17/063750 [patent_app_country] => US [patent_app_date] => 2020-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9007 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063750 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/063750
Diiodohydroxyquinoline for the treatment of clostridium difficile infection Oct 5, 2020 Issued
Array ( [id] => 20262862 [patent_doc_number] => 12433830 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-07 [patent_title] => Anti-aging compositions and methods of use thereof [patent_app_type] => utility [patent_app_number] => 17/762817 [patent_app_country] => US [patent_app_date] => 2020-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6326 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17762817 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/762817
Anti-aging compositions and methods of use thereof Sep 22, 2020 Issued
Array ( [id] => 18056197 [patent_doc_number] => 20220387283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => HAIR GROWTH AGENT [patent_app_type] => utility [patent_app_number] => 17/769990 [patent_app_country] => US [patent_app_date] => 2020-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8210 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769990 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/769990
HAIR GROWTH AGENT Sep 22, 2020 Abandoned
Array ( [id] => 17881206 [patent_doc_number] => 20220296683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => ORAL DELIVERY SYSTEM [patent_app_type] => utility [patent_app_number] => 17/762225 [patent_app_country] => US [patent_app_date] => 2020-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17013 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -42 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17762225 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/762225
ORAL DELIVERY SYSTEM Sep 20, 2020 Abandoned
Array ( [id] => 16569148 [patent_doc_number] => 20210008154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => METHODS AND REAGENTS FOR EFFICIENT AND TARGETED DELIVERY OF THERAPEUTIC MOLECULES TO CXCR4 CELLS [patent_app_type] => utility [patent_app_number] => 17/026543 [patent_app_country] => US [patent_app_date] => 2020-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16405 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17026543 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/026543
Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells Sep 20, 2020 Issued
Array ( [id] => 18056524 [patent_doc_number] => 20220387610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => PEPTIDE-CONJUGATED PRODRUGS [patent_app_type] => utility [patent_app_number] => 17/761496 [patent_app_country] => US [patent_app_date] => 2020-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23256 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -42 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761496 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/761496
Peptide-conjugated prodrugs Sep 17, 2020 Issued
Array ( [id] => 18518512 [patent_doc_number] => 11708392 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-25 [patent_title] => Peptide conjugates [patent_app_type] => utility [patent_app_number] => 17/012724 [patent_app_country] => US [patent_app_date] => 2020-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 44 [patent_no_of_words] => 35551 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17012724 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/012724
Peptide conjugates Sep 3, 2020 Issued
Menu